IBANDRONATE SODIUM
Substance profile for UNII J12U072QL0, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 23663991Substance Identity#
- UNII
- J12U072QL0
- Preferred term
- IBANDRONATE SODIUM
- Registry number
- 138926-19-9
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C9H22NO7P2.Na.H2O
Structure render from PubChem CID 23663991Chemical And Database Identifiers#
- InChIKey
- VBDRTGFACFYFCT-UHFFFAOYSA-M
- SMILES
- O.[Na+].CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)([O-])=O
- RxCUI
- 236916
- PubChem
- 23663991
- NCIt
- C1670
- INN ID
- 0
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| IBANDRONATE SODIUM | ACTIVE INGREDIENT | J12U072QL0 | These highlights do not include all the information needed to use BONIVA Tablets safely and effectively. See full prescribing information for BONIVA Tablets. BONIVA® (ibandronate sodium) Tablets Initial U.S. Approval: 2003 | 1 | |
| ibandronate sodium | ACTIVE INGREDIENT | J12U072QL0 | BONIVA (IBANDRONATE SODIUM) TABLET, FILM COATED [GENENTECH, INC.] | 22 | |
| ibandronate sodium | ACTIVE INGREDIENT | J12U072QL0 | BONIVA (IBANDRONATE SODIUM) INJECTION, SOLUTION [GENENTECH, INC.] | 21 | |
| ibandronate sodium | ACTIVE INGREDIENT | J12U072QL0 | IBANDRONATE SODIUM TABLET [DR. REDDY'S LABORATORIES LIMITED] | 13 | |
| IBANDRONATE SODIUM | ACTIVE INGREDIENT | J12U072QL0 | IBANDRONATE SODIUM INJECTION, SOLUTION [HERITAGE PHARMACEUTICALS INC.] | 8 | |
| IBANDRONATE SODIUM | ACTIVE INGREDIENT | J12U072QL0 | IBANDRONATE SODIUM TABLET, FILM COATED [APOTEX CORP] | 8 | |
| IBANDRONATE SODIUM | ACTIVE INGREDIENT | J12U072QL0 | IBANDRONATE SODIUM TABLET [WATSON LABORATORIES, INC.] | 6 | |
| ibandronate sodium | ACTIVE INGREDIENT | J12U072QL0 | IBANDRONATE SODIUM INJECTION, SOLUTION [SAGENT PHARMACEUTICALS] | 5 | |
| IBANDRONATE SODIUM | ACTIVE INGREDIENT | J12U072QL0 | IBANDRONATE SODIUM TABLET [ALVOGEN INC.] | 5 | |
| IBANDRONATE SODIUM | ACTIVE INGREDIENT | J12U072QL0 | IBANDRONATE SODIUM INJECTION, SOLUTION [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] | 4 | |
| IBANDRONATE SODIUM | ACTIVE INGREDIENT | J12U072QL0 | IBANDRONATE SODIUM (IBANDRONATE SODIUM) TABLET [AVKARE, INC.] | 2 | |
| IBANDRONATE SODIUM | ACTIVE INGREDIENT | J12U072QL0 | IBANDRONATE SODIUM INJECTION, SOLUTION [AUROMEDICS PHARMA LLC] | 2 | |
| IBANDRONATE SODIUM | ACTIVE INGREDIENT | J12U072QL0 | IBANDRONATE SODIUM INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC ] | 2 | |